Trial intelligence / Profile preview

Langqing Ata Granules for Hepatic Fibrosis

CTR20150291Phase 2Active

Sponsor
Jiangsu Hospital of Integrated Traditional Chinese and Western Medicine
Start
Apr 2015
Countries
1
01

Overview

A Phase 2 trial of Langqing Ata granules in hepatic fibrosis, sponsored by Jiangsu Hospital of Integrated Traditional Chinese and Western Medicine. Started Apr 2015; status: active.

02

Drugs

Langqing Ata granules
03

Conditions

hepatic fibrosis

Beyond the preview

Go deeper on CTR20150291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call